VSee Health, Inc. Investing Cash Flow
VSee Health, Inc. (VSEE) reported Investing Cash Flow of -$128.75 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- VSee Health, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$2.00K.
- VSee Health, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$126.75K.
- VSee Health, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$7.15K.
- VSee Health, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$7.31K.
- VSee Health, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$29.93K.
- VSee Health, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$26.14K.
- VSee Health, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$4.33K, a 100.00% decline from fiscal 2022.
- VSee Health, Inc. net cash provided by (used in) investing activities for fiscal 2022 was $110.12M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$128.75K 10-Q · filed 2026-08-14 | -$135.90K derived: sum of 3 quarters · filed 2026-08-14 | -$143.21K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$126.75K 10-Q · filed 2026-05-15 | -$133.90K derived: sum of 2 quarters · filed 2026-05-15 | -$141.21K derived: sum of 3 quarters · filed 2026-05-15 | -$144.81K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$7.15K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$14.46K derived: sum of 2 quarters · filed 2026-03-31 | -$18.05K derived: sum of 3 quarters · filed 2026-08-14 | -$29.93K 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$7.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$10.90K derived: sum of 2 quarters · filed 2026-08-14 | -$22.78K 10-Q · filed 2025-11-14 | -$27.54K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | -$3.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$15.47K 10-Q · filed 2026-08-14 | -$20.23K derived: sum of 3 quarters · filed 2026-08-14 | -$25.22K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$11.87K 10-Q · filed 2026-05-15 | -$16.63K derived: sum of 2 quarters · filed 2026-05-15 | -$21.63K derived: sum of 3 quarters · filed 2026-05-15 | -$29.28K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -$4.76K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$9.75K derived: sum of 2 quarters · filed 2026-03-31 | -$17.40K derived: sum of 3 quarters · filed 2026-03-31 | -$26.14K 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -$4.99K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-14 | -$12.64K derived: sum of 2 quarters · filed 2025-11-20 | -$21.38K 10-Q · filed 2025-11-14 | -$23.03K derived: sum of 4 quarters · filed 2025-11-20 | |||
| 2024-06-30 | -$7.65K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2025-11-20 | -$16.39K 10-Q/A · filed 2025-11-20 | -$18.04K derived: sum of 3 quarters · filed 2025-11-20 | -$18.04K derived: sum of 4 quarters · filed 2025-11-20 | |||
| 2024-03-31 | -$8.74K 10-Q · filed 2025-10-15 | -$10.38K derived: sum of 2 quarters · filed 2025-10-15 | -$10.38K derived: sum of 3 quarters · filed 2025-10-15 | ||||
| 2023-12-31 | -$1.65K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | -$1.65K derived: sum of 2 quarters · filed 2025-08-29 | -$4.33K 10-K/A · filed 2025-08-29 | $6.52M 10-K · filed 2024-04-12 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$2.69K 10-Q · filed 2024-11-14 | -$290.41K 10-Q · filed 2023-11-20 | ||||
| 2023-06-30 | -$2.69K 10-Q · filed 2024-09-23 | -$290.41K 10-Q · filed 2023-08-21 | |||||
| 2022-12-31 | $110.12M 10-K · filed 2024-04-12 | ||||||
| 2021-12-31 | -$116.73M 10-K · filed 2023-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |